Activated protein C resistance and graft occlusion after coronary artery bypass surgery
Open Access
- 15 July 1995
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 79 (2) , 223-226
- https://doi.org/10.1016/0049-3848(95)91526-q
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass graftingThe American Journal of Cardiology, 1994
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.Journal of Clinical Investigation, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]Blood, 1993
- Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteriesProgress in Cardiovascular Diseases, 1991
- Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi.Heart, 1976